Asymmetric Organic Synthesis and Drug Synthesis Laboratory19
Most of drugs, including Remdesivir® as a potential candidate for COVID-19, have chiral carbon-centers and Thalidomide-scandal had brought the importance of stereoselective synthesis of drugs. In this sense, we pursue the development of practical and efficient asymmetric reactions to apply for the lab-scale or bulk-scale synthesis of chiral drugs. To realize that, we focus on 1) the design and the synthesis of novel chiral catalysts, 2) the development of practical reagents, and 3) the development of novel methodology for C-C, C-O, C-N, or C-B bond formations.
Advisor Professor : Jung, Byunghyuck
Asymmetric Organic Synthesis and Drug Synthesis Laboratory Homepage
Advisor Professor : Jung, Byunghyuck
Asymmetric Organic Synthesis and Drug Synthesis Laboratory Homepage
Co-Author(s)
Related Keyword
Recent Submissions
RSS 1.0
RSS 2.0
ATOM 1.0
- Cu-Catalyzed Synthesis of 2-Silyl-1,3-butadienes from Allenols and Applications to One-Pot Synthesis of Tetrasubstituted Arylsilanes
- Unlocking High Porosity: Post-Synthetic Solvothermal Treatment of Cu-Paddlewheel Based Metal–Organic Cages
- Synthesis of alpha-Borylmethyl-(E)-allylborons via Cu-Catalyzed Diboration of 1-Substituted Allenols and Their Application in Stereoselective Aldehyde Allylation
- Synthesis of alkynamides through reaction of alkyl- or aryl-substituted alkynylaluminums with isocyanates
- Plant-inspired quercetin thin films: universal coatings and their postfunctionalization for non-biofouling applications